 | • レポートコード：GIR-105X10536 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、生ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。生ワクチンの種類別市場規模（一価型生ワクチン、多価型生ワクチン）、用途別市場規模（大人用、子供用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・生ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、GlaxoSmithKline、Pfizer、Novartis、Astellas Pharma、Emergent BioSolutions、AstraZeneca ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：一価型生ワクチン、多価型生ワクチン ・用途別分析2016年-2026年：大人用、子供用 ・生ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・生ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・生ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・生ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・生ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Live Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Live Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Live Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Live Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monovalent Live Vaccines
Multivalent Live Vaccines
Market segment by Application can be divided into
Adults
Children
The key market players for global Live Vaccines market are listed below:
Merck
GlaxoSmithKline
Pfizer
Novartis
Astellas Pharma
Emergent BioSolutions
AstraZeneca
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Live Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Live Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monovalent Live Vaccines
1.2.3 Multivalent Live Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Live Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Live Vaccines Market Size & Forecast
1.4.1 Global Live Vaccines Sales in Value (2016-2026))
1.4.2 Global Live Vaccines Sales in Volume (2016-2026)
1.4.3 Global Live Vaccines Price by Type (2016-2026) & (USD/Dose)
1.5 Global Live Vaccines Production Capacity Analysis
1.5.1 Global Live Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Live Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Live Vaccines Market Drivers
1.6.2 Live Vaccines Market Restraints
1.6.3 Live Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Live Vaccines Product and Services
2.1.4 Merck Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Live Vaccines Product and Services
2.2.4 GlaxoSmithKline Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Live Vaccines Product and Services
2.3.4 Pfizer Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Live Vaccines Product and Services
2.4.4 Novartis Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Astellas Pharma
2.5.1 Astellas Pharma Details
2.5.2 Astellas Pharma Major Business
2.5.3 Astellas Pharma Live Vaccines Product and Services
2.5.4 Astellas Pharma Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Emergent BioSolutions
2.6.1 Emergent BioSolutions Details
2.6.2 Emergent BioSolutions Major Business
2.6.3 Emergent BioSolutions Live Vaccines Product and Services
2.6.4 Emergent BioSolutions Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Live Vaccines Product and Services
2.7.4 AstraZeneca Live Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Live Vaccines Sales by Manufacturer
3.1 Global Live Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Live Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Live Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Live Vaccines Manufacturer Market Share
3.4.2 Top 6 Live Vaccines Manufacturer Market Share
3.5 Global Live Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Live Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Live Vaccines Market Size by Region
4.1.1 Global Live Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Live Vaccines Revenue by Region (2016-2026)
4.2 North America Live Vaccines Revenue (2016-2026)
4.3 Europe Live Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Live Vaccines Revenue (2016-2026)
4.5 South America Live Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Live Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Live Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Live Vaccines Revenue by Type (2016-2026)
5.3 Global Live Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Live Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Live Vaccines Revenue by Application (2016-2026)
6.3 Global Live Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Live Vaccines Sales by Type (2016-2026)
7.2 North America Live Vaccines Sales by Application (2016-2026)
7.3 North America Live Vaccines Market Size by Country
7.3.1 North America Live Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Live Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Live Vaccines Sales by Type (2016-2026)
8.2 Europe Live Vaccines Sales by Application (2016-2026)
8.3 Europe Live Vaccines Market Size by Country
8.3.1 Europe Live Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Live Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Live Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Live Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Live Vaccines Market Size by Region
9.3.1 Asia-Pacific Live Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Live Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Live Vaccines Sales by Type (2016-2026)
10.2 South America Live Vaccines Sales by Application (2016-2026)
10.3 South America Live Vaccines Market Size by Country
10.3.1 South America Live Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Live Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Live Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Live Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Live Vaccines Market Size by Country
11.3.1 Middle East & Africa Live Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Live Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Live Vaccines Typical Distributors
12.3 Live Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Live Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Live Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Live Vaccines Product and Services
Table 6. Merck Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Live Vaccines Product and Services
Table 10. GlaxoSmithKline Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Live Vaccines Product and Services
Table 14. Pfizer Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Live Vaccines Product and Services
Table 18. Novartis Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Astellas Pharma Major Business
Table 21. Astellas Pharma Live Vaccines Product and Services
Table 22. Astellas Pharma Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 24. Emergent BioSolutions Major Business
Table 25. Emergent BioSolutions Live Vaccines Product and Services
Table 26. Emergent BioSolutions Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 28. AstraZeneca Major Business
Table 29. AstraZeneca Live Vaccines Product and Services
Table 30. AstraZeneca Live Vaccines Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Live Vaccines Sales by Manufacturer (2019-2021e) & (K Doses)
Table 32. Global Live Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Live Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Live Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 35. Head Office and Live Vaccines Production Site of Key Manufacturer
Table 36. Global Live Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 37. Global Live Vaccines Sales by Region (2021-2026) & (K Doses)
Table 38. Global Live Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Live Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Live Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 41. Global Live Vaccines Sales by Type (2021-2026) & (K Doses)
Table 42. Global Live Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Live Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Live Vaccines Price by Type (2016-2021e) & (USD/Dose)
Table 45. Global Live Vaccines Price by Type (2021-2026) & (USD/Dose)
Table 46. Global Live Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 47. Global Live Vaccines Sales by Application (2021-2026) & (K Doses)
Table 48. Global Live Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Live Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Live Vaccines Price by Application (2016-2021e) & (USD/Dose)
Table 51. Global Live Vaccines Price by Application (2021-2026) & (USD/Dose)
Table 52. North America Live Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 53. North America Live Vaccines Sales by Country (2021-2026) & (K Doses)
Table 54. North America Live Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Live Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Live Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 57. North America Live Vaccines Sales by Type (2021-2026) & (K Doses)
Table 58. North America Live Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 59. North America Live Vaccines Sales by Application (2021-2026) & (K Doses)
Table 60. Europe Live Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 61. Europe Live Vaccines Sales by Country (2021-2026) & (K Doses)
Table 62. Europe Live Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Live Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Live Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 65. Europe Live Vaccines Sales by Type (2021-2026) & (K Doses)
Table 66. Europe Live Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 67. Europe Live Vaccines Sales by Application (2021-2026) & (K Doses)
Table 68. Asia-Pacific Live Vaccines Sales by Region (2016-2021e) & (K Doses)
Table 69. Asia-Pacific Live Vaccines Sales by Region (2021-2026) & (K Doses)
Table 70. Asia-Pacific Live Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Live Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Live Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 73. Asia-Pacific Live Vaccines Sales by Type (2021-2026) & (K Doses)
Table 74. Asia-Pacific Live Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 75. Asia-Pacific Live Vaccines Sales by Application (2021-2026) & (K Doses)
Table 76. South America Live Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 77. South America Live Vaccines Sales by Country (2021-2026) & (K Doses)
Table 78. South America Live Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Live Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Live Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 81. South America Live Vaccines Sales by Type (2021-2026) & (K Doses)
Table 82. South America Live Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 83. South America Live Vaccines Sales by Application (2021-2026) & (K Doses)
Table 84. Middle East & Africa Live Vaccines Sales by Country (2016-2021e) & (K Doses)
Table 85. Middle East & Africa Live Vaccines Sales by Country (2021-2026) & (K Doses)
Table 86. Middle East & Africa Live Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Live Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Live Vaccines Sales by Type (2016-2021e) & (K Doses)
Table 89. Middle East & Africa Live Vaccines Sales by Type (2021-2026) & (K Doses)
Table 90. Middle East & Africa Live Vaccines Sales by Application (2016-2021e) & (K Doses)
Table 91. Middle East & Africa Live Vaccines Sales by Application (2021-2026) & (K Doses)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Live Vaccines Typical Distributors
Table 95. Live Vaccines Typical Customers
List of Figures
Figure 1. Live Vaccines Picture
Figure 2. Global Live Vaccines Sales Market Share by Type in 2020
Figure 3. Monovalent Live Vaccines
Figure 4. Multivalent Live Vaccines
Figure 5. Global Live Vaccines Sales Market Share by Application in 2020
Figure 6. Adults
Figure 7. Children
Figure 8. Global Live Vaccines Market Size, (USD Million) & (K Doses): 2020 VS 2021 VS 2026
Figure 9. Global Live Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Live Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Live Vaccines Sales (2016-2026) & (K Doses)
Figure 30. Global Live Vaccines Production Capacity (2016-2026) & (K Doses)
Figure 31. Global Live Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Live Vaccines Market Drivers
Figure 33. Live Vaccines Market Restraints
Figure 34. Live Vaccines Market Trends
Figure 35. Global Live Vaccines Sales Market Share by Manufacturer in 2020
Figure 36. Global Live Vaccines Revenue Market Share by Manufacturer in 2020
Figure 37. Live Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Live Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Live Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Live Vaccines Sales Market Share by Region (2016-2026)
Figure 41. Global Live Vaccines Revenue Market Share by Region (2016-2026)
Figure 42. North America Live Vaccines Revenue (2016-2026) & (USD Million)
Figure 43. Europe Live Vaccines Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Live Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. South America Live Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Live Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. Global Live Vaccines Sales Market Share by Type (2016-2026)
Figure 48. Global Live Vaccines Revenue Market Share by Type (2016-2026)
Figure 49. Global Live Vaccines Price by Type (2016-2026) & (USD/Dose)
Figure 50. Global Live Vaccines Sales Market Share by Application (2016-2026)
Figure 51. Global Live Vaccines Revenue Market Share by Application (2016-2026)
Figure 52. Global Live Vaccines Price by Application (2016-2026) & (USD/Dose)
Figure 53. North America Live Vaccines Sales Market Share by Country (2016-2026)
Figure 54. North America Live Vaccines Revenue Market Share by Country (2016-2026)
Figure 55. North America Live Vaccines Sales Market Share by Type (2016-2026)
Figure 56. North America Live Vaccines Sales Market Share by Application (2016-2026)
Figure 57. Europe Live Vaccines Sales Market Share by Country (2016-2026)
Figure 58. Europe Live Vaccines Revenue Market Share by Country (2016-2026)
Figure 59. Europe Live Vaccines Sales Market Share by Type (2016-2026)
Figure 60. Europe Live Vaccines Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Live Vaccines Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Live Vaccines Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Live Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Live Vaccines Sales Market Share by Application (2016-2026)
Figure 65. South America Live Vaccines Sales Market Share by Country (2016-2026)
Figure 66. South America Live Vaccines Revenue Market Share by Country (2016-2026)
Figure 67. South America Live Vaccines Sales Market Share by Type (2016-2026)
Figure 68. South America Live Vaccines Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Live Vaccines Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Live Vaccines Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Live Vaccines Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Live Vaccines Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
ヒト混合ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 A combination vaccine is designed to provide protection against two or more diseases or against single disease caused by completely different or similar organism. A combination vaccine also boosts the immune system to fight against infection. These vaccines contain two or more antigens that are eith…- 世界の水痘生ワクチン市場 2021：企業別、地域別、種類・用途別 The Varicella Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 抗感染ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases. Scope of the Report: This report focuses on the Anti-Infective Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report …
- 獣医ワクチンの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. Scope of the Report: This report focuses on the Veterinary Vaccines in global market, especially in North America, Europe and Asia-Pacific,…
- PRRSワクチンの世界市場2018-2025 There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.The PRRS V…